Progress in the Use of Induced Pluripotent Stem Cell-Derived Neural Cells for Traumatic Spinal Cord Injuries in Animal Populations: Meta-Analysis and Review

Abstract

Induced pluripotent stem cells (iPSCs) are cells genetically reprogrammed from somatic cells, which can be differentiated into neurological lineages with the aim to replace or assist damaged neurons in the treatment of spinal cord injuries (SCIs) caused by physical trauma. Here, we review studies addressing the functional use of iPSC‐derived neural cells in SCIs and perform a meta‐analysis to determine if significant motor improvement is restored after treatment with iPSC‐derived neural cells compared with treatments using embryonic stem cell (ESC)‐derived counterpart cells and control treatments. Overall, based on locomotion scales in rodents and monkeys, our meta‐analysis indicates a therapeutic benefit for SCI treatment using neural cells derived from either iPSCs or ESCs, being this of importance due to existing ethical and immunological complications using ESCs. Results from these studies are evidence of the successes and limitations of iPSC‐derived neural cells in the recovery of motor capacity. stem cells translational medicine 2019;8:681&693

The Advances in Biomedical Applications of Carbon Nanotubes

“…Stem cells and their application for tissue engineering and medicine attracted the attention of researchers around the world during the last decades. In fact, stem cells have been considered as a magic bullet to treat various pathologies, including oncology, cardiology, dentistry, neurology, and wound management [140][141][142]. There is growing evidence that CNTs could be used as a cell substrate, and could then modulate proliferation and differentiation of various types of stem cells [143].…”

The repair and autophagy mechanisms of hypoxia-regulated bFGF-modified primary embryonic neural stem cells in spinal cord injury

“…Cell‐based therapies have promising potential for promoting recovery following SCI . In numerous preclinical studies, stem cells, growth factors, vectors, or a combination of all three have been shown to improve neurological function.…”

Neglected No More: Emerging Cellular Therapies in Traumatic Injury

“…A meta-analysis examining 6 randomized controlled trials involving iPSC derivatives that have been differentiated into neural precursors, oligodendrocyte progenitors or astrocytes in rat models of spinal cord injury concluded that rats which received therapy displayed improved locomotor function [ 169 ]. A recent meta-analysis which evaluated preclinical data involving a variety of rodent and monkey models for spinal cord injury also displayed hopeful results, with significant motor improvement after application of iPSC-derived neural cells noted in comparison to controls [ 170 ]. Current clinical trials involve the use of iPSCs in modeling various disease types, include ophthalmologic, cardiovascular, and neurologic ( clinicaltrials.gov , NCT03696628, NCT03971812, NCT02815072, NCT03853252).…”